Login

Jon Pilcher, CEO, Neuren Pharmaceuticals Ltd 00:00:00

Share On Facebook Share On Twitter

Neuren Pharmaceuticals hails FDA approval for trofinetide

Recent Videos

00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper
00:10:00
A $10M Company with a $147M NPV:Akora Resources’ High-Grade Iron Ore Opportunity in Madagascar|Peter Bird,Managing Director,Akora Resources Limited
00:10:00
Lomiko Metals: Building North America’s Largest Undeveloped Graphite Asset with Non-Dilutive Government Backing|Gordana Slepcev,CEO,Lomiko Metals Inc
00:10:00
Apollo Silver: Building a Next-Generation Silver Champion with Flagship U.S. Assets and World-Class Growth Potential in Mexico|ROSS McELROY,CEO,Apollo Silver Crop
00:10:00
Contango Ore and Dolly Varden Silver Announce Merger to Create North American Precious Metals Powerhouse|Rick Van Nieuwenhuyse,CEO,Contango Ore
00:10:00
Turning Energy Infrastructure Into a Critical Mineral Engine|Bill McClain,Head of Investor Relations,LibertyStream Infrastucture Partners Inc
00:10:00
Cerrado Gold Eyes Massive Growth: Projecting $488 Million in Free Cash Flow by 2030|Mark Brennan,CEO,Cerrado Gold
00:10:00
Dryden Gold Accelerates Growth with $7.8M Financing and Major 2026 Drill Program in Ontario’s Prolific Gold Belt|Trey Wasser,CEO,Dryden Gold Corp
00:10:00
Sparton Resources CEO Lee Barker Targets 2025–26 Drilling at Oaks Gold Project Near Alamos Mine|Lee Barker,CEO,Sparton Resources
00:10:00
Talisker Resources Delivers First Gold Sales and Outlines 5-Year Path to 200,000+ Ounces Annual Production|Terry Harbort,CEO,Talisker Resources Ltd
00:10:00
Nuvos Therapeutics: Advancing Oxygen Nanobubble Therapy with Breakthrough Phase 2B Programs in Oncology, Stroke, and Respiratory Distress|Evan Unger,MD,NuvOx Therapeutics
00:10:00
Phenom Resources Advances Nevada Gold Portfolio with Active Drilling, Strategic Financing, and Multiple Upcoming Catalysts|Paul Cowley,CEO,Phenom Resources
00:10:00
Benton Resources Unlocks World-Class Copper-Gold Potential in Newfoundland with District-Scale Exploration Success|STEPHEN STARES,CEO,Benton Resources
00:10:00
Positioned at the Heart of Global Supply Chain Shift with UK, US, Uganda, and Brazil Projects Driving Ex-China Growth|Tim Harrison,Managing Director, Ionic Rare Earths Limited
00:10:00
Dakota Gold Unveils $2.1B Gold Project with Robust Economics, Long Mine Life, and Strategic U.S. Advantage|Robert Quartermain,CEO,Dakota Gold Corp

Suggestions

00:10:00
CEO Juha Saarela Talks Customer Expansion, Sales Performance, and Profit Generation | Juha Saarela, CEO of Puuil OYj.
00:10:00
Adapting Safety Protocols During Pandemic Challenges | Lisa A Grow, CEO, Idacorp Inc.
00:10:00
Early-stage venture capital firm investing at the two forces|Noramay Cadena,Managing Partner,Supply Change Capital
00:10:00
"Embark on an insightful journey with John Lai, the dynamic CEO & President of PetVivo Holdings, Inc., as he unveils the company's visionary roadmap in a groundbreaking interview."|Mr. Lai has been a director and senior executive officer of PetVivo Holdin
00:10:00
Managing Transmission Investments and Climate Resilience | Rui Chammas, CEO, CTEEP Companhia de Transmissao de Energia Eletrica Paulista.
00:10:00
The Importance of Estate Planning and Family Mission Statements | Sharon K. Weaver, President, Mission Financial Planning.
00:10:00
Azure Minerals' Transition to Nickel Mining: Insights from Managing Director Tony Rivera
00:10:00
Navigating Market Volatility: Insights on Shorting Indices and Long-Term Investing | Jeremy Grantham, co-founder , GMO LLC.
00:10:00
Valérie Bodson on Amundi's Growth, ESG Strategy, and Market Outlook | Valérie Baudson, CEO, Amundi .
00:10:00
From Molecular Biology to Biotech Entrepreneurship: Pioneering Antimicrobial Therapies and Novel Drug Development in Infectious Disease | Jeffrey Stei ,CEO, Cidara Therapeutics Inc.
00:10:00
Insights from the 2023 NAPFA Conference and the Debt Ceiling Debate |Dave O’Brien, Founder, EVOadvisers.
00:10:00
I encountered issues accessing the Comparably website. However, based on available information from other sources, HTC Corp's company culture is generally rated as average, with a focus on innovation but challenges in leadership and employee satisfaction.

© 2017 - Neuhu+